MR
Highly rated in
3
conditions

Dr. Michael E. Rytting

Lakeshore Health Partners - Pediatrics & Internal Medicine
Holland, MI
Highly rated in
3
conditions
Specialties:Pediatrics | Pediatric Hematology Oncology
Experience:33 Years
Accepts:New PatientsMedicare
Highly rated in
3
conditions
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Michael E. Rytting's experience treating your condition:
About Dr. Michael E. Rytting

Michael Rytting is a Pediatrics specialist and a Pediatric Hematologist Oncology expert in Holland, Michigan. Rytting has been practicing medicine for over 33 years and is highly rated in 3 conditions, according to our data. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Childhood Pancreatitis, Bone Marrow Transplant, and Bone Marrow Aspiration. He is licensed to treat patients in Texas and Michigan. Rytting is currently accepting new patients.

His clinical research consists of co-authoring 55 peer reviewed articles and participating in 6 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Michael E. Rytting it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Michael E. Rytting accepts the following insurance:

  •  Blue Cross Blue Shield
  •  Ambetter
  •  Priority Health
Call to see if your plan is accepted.
Locations
3235 N Wellness Dr, Holland, MI 49424
Background & Education
Graduate Institution
University Of Michigan Medical School, 1990
Specialties
Pediatrics
Pediatric Hematology Oncology
Licenses
Internal Medicine in MI
Hospital Affiliations
Holland Hospital
Languages Spoken
English
Spanish
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
Enrollment Status: Active, not recruiting
Publish Date: December 07, 2022
Intervention Type: Drug, Other, Radiation
Study Drugs: ClofarabineCyclophosphamideCytarabineDasatinibDaunorubicin HydrochlorideDexamethasoneDoxorubicin HydrochlorideEtoposideHydrocortisone Sodium SuccinateLeucovorin CalciumMercaptopurineMethotrexatePegaspargasePrednisoneThioguanineVincristine Sulfate
Study Phase: Phase 3
A Phase 1/2 Multi-Center Study Evaluating the Safety and Efficacy of KTE-X19 in Pediatric and Adolescent Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (ZUMA-4)
Enrollment Status: Active, not recruiting
Publish Date: November 04, 2022
Intervention Type: Biological, Drug
Study Drugs: KTE-X19 Brexucabtagene AutoleucelFludarabineCyclophosphamide
Study Phase: Phase 1/Phase 2
A Phase II Study of Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma
Enrollment Status: Completed
Publish Date: August 26, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Pilot Study Evaluating the Feasibility of an Intercontinental Phase III Chemotherapy Study for Patients With Choroid Plexus Tumors
Enrollment Status: Terminated
Publish Date: February 27, 2020
Intervention Type: Drug, Radiation
Study Phase: Phase 3
Augmented Berlin-Frankfurt-Munster Therapy for Adolescents/Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Enrollment Status: Completed
Publish Date: September 10, 2019
Intervention Type: Drug
Study Phase: Phase 2
Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Enrollment Status: Terminated
Publish Date: June 11, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials -
55 Total Publications
Asparaginase-Associated Pancreatitis in Pediatric Patients with Acute Lymphoblastic Leukemia: Current Perspectives.
Journal: Paediatric drugs
Published: July 25, 2021
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
TQ
Dr. Troy C. Quigg
Pediatric Hematology Oncology | Hematology | Oncology
Highly rated in
6
conditions
Pediatric Hematology Oncology
Hematology
Oncology

BHSH Spectrum Health West Michigan

Helen DeVos Children's Hospital (Blood & Bone Marrow Transplant) - Grand Rapids

100 Michigan St Ne, 
Grand Rapids, MI 
 23.5 mi

Troy Quigg is a Pediatric Hematologist Oncology specialist and a Hematologist in Grand Rapids, Michigan. Quigg is highly rated in 6 conditions, according to our data. His top areas of expertise are Severe Combined Immunodeficiency (SCID), Bare Lymphocyte Syndrome, Omenn Syndrome, Reticuloendotheliosis, and Bone Marrow Transplant. He is licensed to treat patients in Michigan. Quigg is currently accepting new patients.

LS
Dr. Laurie H. Seaver
Pediatrics | Medical Genetics
Highly rated in
6
conditions
Pediatrics
Medical Genetics

BHSH Spectrum Health West Michigan

Helen DeVos Children's Hospital (Medical Genetics)

25 Michigan St Ne, 
Grand Rapids, MI 
 23.5 mi

Laurie Seaver is a Pediatrics specialist and a Medical Genetics expert in Grand Rapids, Michigan. Seaver has been practicing medicine for over 36 years and is highly rated in 6 conditions, according to our data. Her top areas of expertise are Hypotonia, 1p36 Deletion Syndrome, Congenital Contractures, and Smith-Magenis Syndrome. She is licensed to treat patients in Hawaii and Michigan. Seaver is currently accepting new patients.

JF
Dr. James B. Fahner
Pediatrics | Pediatric Hematology Oncology | Hematology Oncology
Highly rated in
1
conditions
Pediatrics
Pediatric Hematology Oncology
Hematology Oncology

BHSH Spectrum Health West Michigan

Spectrum Health Butterworth Hospital

100 Michigan St Ne, 
Grand Rapids, MI 
 23.5 mi

James Fahner is a Pediatrics specialist and a Pediatric Hematologist Oncology expert in Grand Rapids, Michigan. Fahner has been practicing medicine for over 40 years and is highly rated in 1 condition, according to our data. His top area of expertise is Evans Syndrome. He is licensed to treat patients in Michigan. Fahner is currently accepting new patients.